In contrast, only three drug candidates (Arsenenous acid CTD 00000922, IMIQUIMOD BOSS and QUINOLINE CTD 00001749) were identified for TLR8. These findings offer novel insights into the post-transcriptional regulation and therapeutic targeting of ischemic stroke (Figure 6). The gene discussed is TLR8; the disease is ischemic stroke.